GeneThera Acquires Majority Stake in Applied Genetics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneThera today announced it has acquired a majority ownership of molecular diagnostic firm Applied Genetics for an undisclosed amount.

GeneThera said the deal is part of a broader strategy to begin revenue generation at Applied Genetics, which is based in Monterrey, Mexico and focuses on commercializing tests for Johne's disease in Mexico.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.